S 854 · introduced · significant
Risky Research Review Act
- government reform
What this bill does
- Creates a new independent board to review and approve federal funding for high-risk life sciences research.
- Affects federal agencies and research institutions receiving grants for studies involving dangerous pathogens or organisms.
- Establishes compliance requirements and attestation processes with no specified budget authorization or timeline.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How would the new independent board balance preventing dangerous research outcomes against potential delays in funding legitimate life sciences studies?
- 02
Which federal agencies would bear the costs of the new compliance and attestation processes, and how might this affect their research budgets?
- 03
What specific criteria would the board use to define 'high-risk' research, and who determines whether existing funded projects must undergo retrospective review?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · R-KY
Rand Paul
Citizen cosponsors
0
In Congress
1/ 100
Senators cosponsoring
Introduced 2025-09-17
Joining the bill
Legislative timeline
2025-09-17 · senate · Calendars
Placed on Senate Legislative Calendar under General Orders. Calendar No. 164.
2025-09-17 · senate · Committee
Committee on Homeland Security and Governmental Affairs. Reported by Senator Paul without amendment. Without written report.
2025-09-17 · Committee
Committee on Homeland Security and Governmental Affairs. Reported by Senator Paul without amendment. Without written report.
2025-07-30 · senate · Committee
Committee on Homeland Security and Governmental Affairs. Ordered to be reported without amendment favorably.
2025-03-05 · senate · IntroReferral
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
2025-03-05 · IntroReferral
Introduced in Senate
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.